From: The role of mitochondrial genomics in patients with non-alcoholic steatohepatitis (NASH)
Variable | NAFLD without | NAFLD with | P-value |
---|---|---|---|
p. fibrosis (N = 152) | p. fibrosis (N = 95) | ||
Age (yrs) | 44.03 ± 11.08 | 46.73 ± 11.35 | 0.0609 |
BMI (kg/m2) | 48.05 ± 8.94 | 49.23 ± 10.19 | 0.1752 |
WBC (x 103/uL) | 8.16 ± 2.35 | 8.77 ± 9.15 | 0.5668 |
Platelets (x 103/uL) | 290.32 ± 63.79 | 267.63 ± 67.91 | 0.0094 |
Insulin Resistance | 2.42 ± 1.16 | 8.69 ± 11.25 | 0.0009 |
Glucose (mg/dL) | 111.01 ± 36.85 | 120.25 ± 43.34 | 0.2630 |
ALT (U/L) | 32.38 ± 17.62 | 49.95 ± 37.96 | <.0001 |
AST (U/L) | 23.97 ± 11.78 | 36.88 ± 30.51 | <.0001 |
Triglycerides (mg/dL) | 159.48 ± 86.89 | 185.17 ± 119.26 | 0.0760 |
LDL (mg/dL) | 112.12 ± 36.03 | 109.52 ± 35.33 | 0.7968 |
Total cholesterol (mg/dL) | 193.96 ± 39.81 | 188.62 ± 41.43 | 0.3486 |
HDL (mg/dL) | 48.38 ± 13.47 | 42.69 ± 11.20 | 0.0004 |
Male: N (%) | 26 (17.1Â %) | 45 (47.4Â %) | <.0001 |
White: N (%) | 119 (78.3Â %) | 77 (81.1Â %) | 0.6017 |
HAPLOTYPE, N (%) | |||
 H | 58 (38.2 %) | 35 (36.8 %) | 0.8355 |
 L | 24 (15.8 %) | 4 (4.2 %) | 0.0052 |
 U | 17 (11.2 %) | 14 (14.7 %) | 0.4123 |
 Other | 13 (8.6 %) | 18 (18.9 %) | 0.0164 |
 K | 12 (7.9 %) | 11 (11.6 %) | 0.3324 |
 J | 11 (7.2 %) | 5 (5.3 %) | 0.5398 |
 T | 10 (6.6 %) | 5 (5.3 %) | 0.6736 |
PNPLA3_SNP, N (%) | |||
 CC | 94 (61.8 %) | 38 (40.0 %) | 0.0008 |
 GC | 38 (25.0 %) | 52 (54.7 %) | <0.0001 |
 GG | 20 (13.2 %) | 5 (5.3 %) | 0.0454 |